This Week: Live From the World’s Largest Alzheimer’s Research Conference
The Being Patient team is on the ground this week at the Alzheimer's Association International Conference — AAIC 2025 — in Toronto.
From our editor in chief Deborah Kan getting a voluntary brain MRI in the middle of a conference center to the latest updates on Roche’s experimental new Alzheimer’s drug, we’re dispatching this week from the Alzheimer’s Association International Conference, or AAIC, in Toronto, Canada.
This week, our Being Patient reporting team is on the ground at AAIC 2025 in Toronto, where researchers are delving into a wide spectrum of emerging Alzheimer’s risk factors. Among the panels and papers we’re following closely: lifestyle and resilience across the lifespan, addressing how exercise, diet, sleep, and social engagement can shape cognitive aging trajectories; the role of lead exposure and other early-life environmental hazards in predisposing the brain to memory decline later in life; and broader social determinants of health, including access to food assistance programs like SNAP and income inequality, as key contributors to dementia risk across populations.
At AAIC, the coverage extends beyond molecular markers to human-centered themes: How do diet and gut health influence cognition? What’s the interplay between environmental toxins and socioeconomic status? How is public policy-relevant research on societal supports (or their absence) helping to shape outcomes in aging and Alzheimer’s disease?
We’ll be highlighting panels and posters that spotlight these real-world factors driving research, equity, and prevention strategies across diverse global communities. Watch our reporting throughout the week!
